Safety and efficacy of silibinin in patients with brain metastases after stereotactic radiosurgery (SRS): The SUSTAIN trial

Category Primary study
JournalANNALS OF ONCOLOGY
Year 2023
This article has no abstract
Epistemonikos ID: 0d9f83baacdc94225aead1262556133cda75a983
First added on: Feb 16, 2025